Daniel Trencher has sold TDOC and made no open-market buys since Nov 2020

Daniel Trencher is a corporate strategy and product executive with more than two decades of experience at the intersection of digital technology and healthcare, most notably at Teladoc Health, Inc.( As Chief Strategy Officer at Teladoc Health, he led the company’s corporate strategy group, overseeing development of its long‑range strategic vision, annual operating plan, product roadmap, and business unit go‑to‑market strategies, and was reported as a corporate insider trading Teladoc shares in this role.( During his tenure helping lead strategy and product, Teladoc’s revenue grew from under $10 million in 2011 to $77 million at its 2015 IPO and to approximately $2.6 billion for fiscal year 2024, reflecting Teladoc’s evolution into a leading global virtual care company.(

Earlier in his Teladoc career, Trencher served as Senior Vice President for Corporate Strategy and previously led product management, contributing to the company’s positioning as a global leader in whole‑person virtual care across primary care, mental health, and chronic condition management.( Before joining Teladoc in 2011, he held roles with major health insurers including WellPoint and WellChoice, and he brings extensive experience working with Fortune 50 payors such as Empire BlueCross BlueShield/Anthem.( Following his tenure as Chief Strategy Officer through 2024, Trencher has continued to work in healthcare innovation as a strategic advisor to organizations including Healthnix, ADP Ventures, and DET Advisors, LLC, focusing on growth, digital health, and AI‑enabled care models.(

Written by Perplexity from public sources.